News and Events

  • T-TAS®01 – The Leading Edge in Platelet Thrombus Formation Assessment

    Posted: June 1, 2022

    It’s Not Just Support. It’s Solutions. Innovative Total Platelet Function Analysis using Whole Blood Global evaluation of overall hemostatic ability using physiologic, flow conditions Exclusively from DiaPharma. Advantages of T-TAS® 01 PL Assay Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy…

    Read More

  • Respiratory Research Solutions from DiaPharma

    Posted: May 16, 2022

    It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source for ProAxsis products   Reach out to DiaPharma’s Olivia Stricker, who will be at American Thoracic Society (ATS) 2022 in San Francisco, May 13 – 16. Elevate your clinical research data by measuring active proteases Targets: Drug development evaluating new protease inhibitors or anti-inflammatory…

    Read More

  • Comprehensive Solutions for Anticoagulation Research

    Posted: May 9, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. Thrombin Generation Testing Manual or automated options for studying potential new anticoagulants Technothrombin® TGA*…

    Read More

  • What’s New at DiaPharma?

    Posted: April 28, 2022

    It’s Not Just Support. It’s Solutions. Meet Ryan McCaw Midwest Territory Manager Ryan joined DiaPharma in January of 2022. He obtained his BS in Medicine from the University of Iowa where he also completed the Medical Technology program. He was certified as a Medical Technologist with the ASCP and started his career in medical research…

    Read More

  • Emerging Biomarkers in Alcoholic Liver Disease

    Posted: April 14, 2022

    It’s Not Just Support. It’s Solutions. Non-Invasive Biomarkers for Alcoholic Liver Disease Studies Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcoholic Liver Disease (ALD) and Alcoholic Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into: Disease severity and progression in ALD and…

    Read More

  • Thrombin Generation Assay for Cancer Associated Thrombosis Research

    Posted: April 12, 2022

    It’s Not Just Support. It’s Solutions. Technothrombin® and Ceveron® TGA Thrombin Generation Testing for Cancer-Associated Thrombosis Research Thrombosis is a common complication for individuals with cancer. Risk varies by malignancy type, treatment approaches, and individual risk factors. Thrombin generation assays (TGA) provide a global context of thrombosis. When you want to measure thrombin generation in…

    Read More

  • Assays for your Gene Therapy Research in Rare Diseases

    Posted: March 3, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays for Gene Therapy and Cell Therapy Research in Rare Diseases   HEMOPHILIA A & B Chromogenic FVIII – Coamatic® FVIII, Coatest® SP/SP4 FVIII Sensitive and reproducible, featuring bovine factor reagents Chromogenic FIX – ROX FIX* Bringing chromogenic FIX testing into the next era with unsurpassed sensitivity SICKLE…

    Read More

  • Non-Invasive, Non-Destructive Ecotoxicology Assays

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. Environmental Impact Matters.   PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH NON-INVASIVE, EASY TO USE, ACCURATE ECOTOXICOLOGY ELISAs Use TECO® Mucus Collection Swabs and test kits to test fish: follow individuals and populations over time endocrine disruption – vitellogenin ELISA liver damage – hyaluraonic acid ELISA stress –…

    Read More

  • Go with the Pro – Intact Proinsulin for your Diabetes Research

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro!   TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only active proinsulin. Only 1% to 3% of proinsulin is secreted intact. However, because proinsulin has a longer half-life than insulin, circulating proinsulin…

    Read More

  • You Name It, I’ll Do It – complete solutions for your hemostasis needs

    Posted: February 15, 2022

    It’s Not Just Support. It’s Solutions. Ceveron® s100: Your all-in-one coagulation research analyzer Featuring automated ADAMTS13, Thrombin Generation Testing, FXIII Activity, and full menu of clotting and chromogenic tests Introducing the do-it-all Ceveron® s100, for automated hemostasis research assays. You name it, Ceveron® s100 can do it! Featuring Technofluor® ADAMTS13 as your on-demand ADAMTS13 activity…

    Read More

  • Tools for the puzzle of COVID-related coagulation

    Posted: January 26, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to enhance your COVID-19 Related Research *For research use only. Not for use in diagnostic procedures. Coagulation, Anticoagulation, Fibrinolysis, Thromboinflammation. DiaPharma is your resource for all things bleeding and clotting. Not sure which assays best fit your needs? Give us a call or email to…

    Read More

  • A better way to measure functionally active prothrombin

    Posted: January 13, 2022

    It’s Not Just Support. It’s Solutions. High Quality Assays for the Latest Hemostasis and Anticoagulation Research   Featuring ROX Prothrombin* Provides a prothrombinase based chromogenic method to measure biologically functional FII activity in plasma and FII containing concentrates Non-γ-carboxylated-FII is not activated in this method in contrast to snake venom based prothrombin methods High dilution…

    Read More

  • Non-Invasive Solutions to Help Your Drug Candidate Move Forward

    Posted: December 8, 2021

    Non-Invasive Biomarker Assays for Liver Disease Drug Development Studies   The Need: Non-Invasive, mechanistic biomarkers that add valuable information about your drug candidate’s efficacy Not all biomarkers provide information about the biological mechanism of drug candidates. Specific and comprehensive data are critical when deciding on a clinical trial strategy for a drug candidate. M30®-Apoptosense, M65®…

    Read More

  • Go with the Pro – Intact Proinsulin for your Diabetes Research

    Posted: December 8, 2021

    When it comes to measuring pancreatic Beta cell function, go with the Pro!   TECO® Proinsulin ELISA Why Measure Intact Proinsulin? Proinsulin is the precursor of insulin and Connecting Peptide (C-Peptide). Following synthesis, proinsulin is packaged into secretory granules, where it is processed to C-Peptide and insulin by prohormone convertases (PC1/3 and PC2) and carboxypeptidase…

    Read More

  • Two Fields, One Company – Expertise in Liver Disease and Coagulation

    Posted: November 30, 2021

    It’s Not Just Support. It’s Solutions. Markers for Bleeding and Thrombosis in Liver Disease DiaPharma’s long-time expertise in the Hemostasis and Liver Disease fields means we’re uniquely positioned to deliver solutions. Liver diseases – such as Non-alcoholic fatty liver disease (NAFLD), Alcoholic Hepatitis (AH), and cirrhosis – can be associated with imbalances in coagulation, whether…

    Read More

  • What’s New at DiaPharma?

    Posted: October 25, 2021

    It’s Not Just Support. It’s Solutions. Staff Spotlight Meet Nancy, Executive Assistant We’re excited to welcome Nancy to the DiaPharma team. Nancy writes, “I was born in Farmington Hills Michigan. I have three children; my youngest daughter Brenna is still at home while attending University of Cincinnati. I have been with my husband Tim for…

    Read More

  • Chromogenic Substrates – It’s in our Blood

    Posted: October 21, 2021

    It’s Not Just Support. It’s Solutions. Chromogenic Substrates for your Coagulation, Anticoagulation, and Fibrinolysis Needs Chromogenic substrate technology is in our blood. Chromogenic Substrates for QC, Drug Development, R&D, for Anti-Xa Testing (S-2765), Contact Pathway Studies (S-2302), Thrombin Generation (S-2238), and more. Chromogenic substrates are peptides that react with proteolytic enzymes with the formation of…

    Read More

  • Non-Invasive Solutions for Your NASH Clinical Trials

    Posted: September 16, 2021

    It’s Not Just Support. It’s Solutions. Biomarker Assays for NASH Clinical Trials Non-Invasive Biomarkers for Fatty Liver Disease Research The Problem: In early phase NASH trials, performing liver biopsies to evaluate the effect of a potential drug candidate is not always practical or feasible. These relatively short-duration early trials may not result in significant changes…

    Read More

  • Sickle Cell Matters

    Posted: September 10, 2021

    It’s Not Just Support. It’s Solutions. September is National Sickle Cell Awareness Month, a time to acknowledge and educate how this often-invisible and rare disease impacts over 100,000 people in the U.S., most of whom are of African descent. Treatment can include antibiotics, pain management, intravenous fluids, blood transfusion and surgery. Sickle Cell Disease Association…

    Read More

  • Now available from DiaPharma – CMV Brite™ Turbo Kit for detecting active CMV infection

    Posted: August 18, 2021

    It’s Not Just Support. It’s Solutions. Save Time with CMV Brite™ Turbo Early and rapid diagnosis of active CMV infection is of great importance in avoiding overtreatment with immunosuppressive drugs and in guiding antiviral therapy. The CMV Brite™ Turbo Kit is a rapid immunofluorescence antigenemia kit for in vitro CMV diagnosis. The CMV Brite™ Turbo…

    Read More